| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 2.297 | 1.434 | 1.610 | 889 | 1.044 | 2.117 | 14.040 | 15.889 | 11.845 |
| Total Income - EUR | 0 | 2.297 | 1.434 | 1.610 | 889 | 1.044 | 2.117 | 14.040 | 15.889 | 11.845 |
| Total Expenses - EUR | 1.120 | 2.947 | 2.240 | 4.357 | 4.538 | 2.812 | 4.860 | 7.979 | 10.860 | 11.843 |
| Gross Profit/Loss - EUR | -1.120 | -650 | -806 | -2.747 | -3.649 | -1.768 | -2.743 | 6.061 | 5.029 | 1 |
| Net Profit/Loss - EUR | -1.120 | -719 | -850 | -2.796 | -3.676 | -1.798 | -2.773 | 5.921 | 4.871 | -117 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sivanmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 125 | 36 | 84 | 186 | 687 | 27 | 383 | 301 | 424 | 2.247 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 179 | 0 | 99 | 262 | 0 | 0 |
| Cash | 125 | 36 | 84 | 186 | 508 | 27 | 284 | 39 | 424 | 2.247 |
| Shareholders Funds | -1.075 | -1.783 | -2.603 | -5.350 | -8.922 | -10.551 | -13.090 | -7.209 | -2.317 | -2.421 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.200 | 1.819 | 2.687 | 5.536 | 9.610 | 10.578 | 13.473 | 7.510 | 2.741 | 4.668 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4322 - 4322" | |||||||||
| CAEN Financial Year |
4322
|
|||||||||
Comments - Sivanmed S.r.l.